Form 4: Colgate-Palmolive CEO Sells Shares Under 10b5-1 Plan

Colgate-Palmolive Chairman, President & CEO Noel R. Wallace sold 45,568 shares of common stock for approximately $4.28 million under a Rule 10b5-1 plan.

Summary

• Noel R. Wallace, Chairman, President & CEO of Colgate-Palmolive Co. (CL), sold 45,568 shares of common stock.
• The transaction occurred on February 4, 2026, at a weighted average price of $93.9145 per share.
• The total value of the shares sold was approximately $4,280,490.
• The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Following the transaction, Mr. Wallace directly owns 293,188 shares and indirectly owns 106,616 shares through various trusts and a 401(k) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be a negative signal, the execution under a Rule 10b5-1 plan mitigates concerns about its implications for the company's immediate prospects.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on immediate insider information.

Negatives

• An insider sale by a high-ranking executive, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the executive's direct equity exposure.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, particularly by top executives, are routinely monitored by investors for signals about management's confidence in the company's future prospects. However, sales executed under a Rule 10b5-1 plan are generally viewed as less indicative of a change in sentiment, as they are pre-scheduled to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders may observe the reduction in direct ownership by the CEO, but the Rule 10b5-1 plan context suggests a planned liquidity event rather than a loss of confidence.

Key Dates

Recommendation

The insider sale by CEO Noel R. Wallace, while a reduction in direct holdings, was executed under a pre-arranged Rule 10b5-1 plan. This suggests a planned liquidity event rather than a reaction to new material information. Given the context, this transaction alone does not provide a strong signal for a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Colgate-Palmolive, CL, Insider Sale, Form 4, Noel R. Wallace, CEO, Stock Transaction, Rule 10b5-1